Notify me when Crystal Peak Investment Inc. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| LSBCF | LakeShore Biopharma Co., Ltd | Ordinary Shares, par value $0.0002 per share | 51% | $16,186,426 | 21,021,332 | 0% | Crystal Peak Investment Inc. | 04 Feb 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|